Group One Trading
IMVT icon

Group One Trading’s Immunovant IMVT Stock Holding History

Group One Trading’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
+435,100
New +$13.3M 0.02% 635
2026
Q1 		– Sell
-49,500
Closed -$1.26M – 8132
2025
Q4 		$1.26M Sell
49,500
-24,300
-33% -$542K ﹤0.01% 2692
2025
Q3 		$1.19M Sell
73,800
-4,200
-5% -$68K ﹤0.01% 2852
2025
Q2 		$1.25M Sell
78,000
-343,500
-81% -$5.19M ﹤0.01% 2564
2025
Q1 		$7.2M Buy
421,500
+50,900
+14% +$1.06M 0.02% 814
2024
Q4 		$9.18M Buy
370,600
+9,000
+2% +$255K 0.02% 758
2024
Q3 		$10.3M Buy
361,600
+329,200
+1,016% +$9.71M 0.03% 604
2024
Q2 		$855K Buy
32,400
+26,100
+414% +$742K ﹤0.01% 2128
2024
Q1 		$204K Sell
6,300
-112,800
-95% -$4.12M ﹤0.01% 3549
2023
Q4 		$5.02M Sell
119,100
-445,900
-79% -$16.4M 0.01% 1137
2023
Q3 		$21.7M Buy
565,000
+484,800
+604% +$11M 0.07% 206
2023
Q2 		$1.52M Buy
80,200
+8,000
+11% +$149K ﹤0.01% 1969
2023
Q1 		$1.12M Sell
72,200
-69,800
-49% -$1.21M ﹤0.01% 2040
2022
Q4 		$2.52M Sell
142,000
-58,900
-29% -$742K 0.01% 1637
2022
Q3 		$1.12M Sell
200,900
-31,200
-13% -$153K ﹤0.01% 2455
2022
Q2 		$905K Sell
232,100
-383,200
-62% -$1.66M ﹤0.01% 2852
2022
Q1 		$3.39M Sell
615,300
-707,500
-53% -$4.41M ﹤0.01% 1875
2021
Q4 		$11.3M Buy
1,322,800
+800
+0.1% +$6.6K 0.01% 1017
2021
Q3 		$11.5M Buy
1,322,000
+560,000
+73% +$5.05M 0.01% 972
2021
Q2 		$8.05M Buy
762,000
+751,000
+6,827% +$10.5M 0.01% 1255
2021
Q1 		$176K Buy
+11,000
New +$290K ﹤0.01% 5152

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's IMVT Position: Q2 2026 in Review

Group One Trading sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 20,586 shares — an estimated $627K sold.

Group One Trading first reported a position in IMVT in Q1 2021 and held it in 17 quarters. The position peaked at $5.79M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Group One Trading reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 20,586 Immunovant shares in Q2 2026, an estimated $627K.
  • Group One Trading first reported a position in Immunovant in Q1 2021 and held it in 17 quarters.
  • Group One Trading's Immunovant position peaked at $5.79M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.